{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:47:00Z","timestamp":1791002820074,"version":"4.1.0"},"reference-count":166,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:p>Exogenous hormones are used by more than a hundred million women worldwide as oral contraceptives or for postmenopausal hormone replacement. Oral contraceptives increase the risk of venous thrombosis, of myocardial infarction, and of stroke. The risk is highest during the first year of use. The venous thrombotic risk of oral contraceptives is high among women with coagulation abnormalities and with so-called third-generation contraceptives (containing desogestrel or gestodene). The risk of myocardial infarction does not appear to depend on coagulation abnormalities or the type of oral contraceptive. Hormone replacement therapy increases the risk of venous thrombosis. This risk is also highest in the first year of use and among women with coagulation abnormalities. The risk becomes very high in women with a previous venous thrombosis. Randomized trials have not confirmed a beneficial effect of postmenopausal hormones on the occurrence of myocardial infarction.<\/jats:p>","DOI":"10.1161\/hq0202.102318","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T23:16:47Z","timestamp":1027898207000},"page":"201-210","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":210,"title":["Female Hormones and Thrombosis"],"prefix":"10.1161","volume":"22","author":[{"given":"F.R.","family":"Rosendaal","sequence":"first","affiliation":[{"name":"From the Departments of Clinical Epidemiology (F.R.R., J.P.V.), Hematology (F.R.R.), and Obstetrics, Gynecology and Reproductive Medicine (F.M.H.),. Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Helmerhorst","sequence":"additional","affiliation":[{"name":"From the Departments of Clinical Epidemiology (F.R.R., J.P.V.), Hematology (F.R.R.), and Obstetrics, Gynecology and Reproductive Medicine (F.M.H.),. Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Vandenbroucke","sequence":"additional","affiliation":[{"name":"From the Departments of Clinical Epidemiology (F.R.R., J.P.V.), Hematology (F.R.R.), and Obstetrics, Gynecology and Reproductive Medicine (F.M.H.),. Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"1146","volume":"2","year":"1961","unstructured":"Jordan WM. Pulmonary embolism. Lancet. 1961; 2: 1146\u20131147.","journal-title":"Lancet"},{"key":"e_1_3_2_2_2","first-page":"111.","volume":"1","year":"1963","unstructured":"Boyce J, Fawcett JW, Noall EWP. Coronary thrombosis and Conovid. Lancet. 1963; 1: 111.","journal-title":"Lancet"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07113-9"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07114-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07308-4"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1973.03230060030009"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2601068.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91929-5"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91927-9"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91928-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)12215-7"},{"key":"e_1_3_2_12_2","unstructured":"Virchow R. Phlogose und Thrombose im Gef\u00e4\u03b2system.In: Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt Germany: Staatsdruckerei; 1856."},{"key":"e_1_3_2_13_2","first-page":"267","volume":"13","year":"1967","unstructured":"Records Unit and Research Advisory Service of the Royal College of General Practitioners. Oral contraception and thrombo-embolic disease. J R Coll Gen Pract. 1967; 13: 267\u2013279.","journal-title":"J R Coll Gen Pract"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5586.199"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5658.651"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a121082"},{"key":"e_1_3_2_17_2","first-page":"1399","volume":"1","year":"1973","unstructured":"Boston Collaborative Drug Surveillance Program. Oral contraceptives and venous thromboembolic disease, surgically confirmed gall bladder disease and breast tumours. Lancet. 1973; 1: 1399\u20131404.","journal-title":"Lancet"},{"key":"e_1_3_2_18_2","first-page":"299","volume":"59","year":"1982","unstructured":"Porter JB. Oral contraceptives and nonfatal vascular disease: recent experience. Obstet Gynecol. 1982; 59: 299\u2013302.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_19_2","first-page":"393","volume":"28","year":"1978","unstructured":"Royal College of General Practitioners\u2019 Oral Contraception Study. Oral contraceptives, venous thrombosis, and varicose veins. J R Coll Gen Pract. 1978; 28: 393\u2013399.","journal-title":"J R Coll Gen Pract"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6519.526"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1995.tb00896.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198902093200602"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603273141305"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112148"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90286-0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.1.48"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91926-0"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/01443619509015499"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7270.1190"},{"key":"e_1_3_2_30_2","first-page":"315","volume":"10","year":"1997","unstructured":"Realini JP, Encarnacion CE, Chintapalli KN, Rees CR. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias. J Am Board Fam Pract. 1997; 10: 315\u2013321.","journal-title":"J Am Board Fam Pract"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.1.65"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115799"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7023.83"},{"key":"e_1_3_2_34_2","first-page":"27","volume":"244","year":"1998","unstructured":"Bennet L, Odeberg H. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism. J Intern Med. 1998; 244: 27\u201332.","journal-title":"J Intern Med"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614213"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(99)00011-6"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01257-X"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.19.3.700"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(98)00033-X"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07496-X"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7137.1090"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7305.131"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a019700"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a019702"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64008-1"},{"key":"e_1_3_2_46_2","first-page":"521.","volume":"351","year":"1998","unstructured":"Meirik O. Risks of oral contraceptives. Lancet. 1998; 351: 521.","journal-title":"Lancet"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.3109\/13625187.11661690.1996"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91181-2"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(97)00119-4"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(96)00112-6"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7259.477"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.6.1500"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70289-8"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(98)00014-6"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/5.6.721"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105173442007"},{"key":"e_1_3_2_57_2","unstructured":"World Health Organization. Cardiovascular Disease and Steroid Hormone Contraception: Report of a WHO Scientific Group. Geneva Switzerland: World Health Organization; 1998. WHO Technical Report Series No. 877."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.192707.x"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.3.1004"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648978"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1653788"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05323.x"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06092-4"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613958"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613959"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613960"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02853.x"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.761"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702063360601"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107193450302"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008173430702"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.769"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(99)00121-8"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702063360602"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.10.3329"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90008-X"},{"key":"e_1_3_2_77_2","first-page":"566","volume":"80","year":"1998","unstructured":"Eichinger S, Stumpflen A, Hirschl M, Bialonczyk C, Herkner K, Stain M, Schneider B, Pabinger I, Lechner K, Kyrle PA. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost. 1998; 80: 566\u2013569.","journal-title":"Thromb Haemost"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411104"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614554"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656023"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614409"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650249"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614442"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91803-5"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615049"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540400055031"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.5712013.x"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90166-3"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656061"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613747"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614323"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.1.49"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10266-0"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5599.193"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197304262881703"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5965.241"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112874"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91205-4"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03290230040022"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-1-58"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03280410045016"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198109103051104"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198109173051205"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)02358-1"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)12393-8"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)12394-6"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.98.11.1058"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(97)00118-2"},{"key":"e_1_3_2_110_2","first-page":"627","volume":"347","year":"1996","unstructured":"Jick H, Jick S, Myers MW, Vasilakis C. Risk of acute myocardial infarction and low-dose combined oral contraceptives. Lancet. 1996; 347: 627\u2013628.","journal-title":"Lancet"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7198.1579"},{"key":"e_1_3_2_112_2","unstructured":"Tanis BC van den Bosch MAAJ Kemmeren JM Manger Cats V Helmerhorst FM Algra A van der Graaf Y Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. In press."},{"key":"e_1_3_2_113_2","first-page":"2750","volume":"89","year":"1997","unstructured":"Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr, Raghunathan TE, Koepsell TD, Reitsma PH. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 1997; 89: 2750\u20132754.","journal-title":"Blood"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.5.1747"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.97.11.1037"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-12-1016"},{"key":"e_1_3_2_117_2","first-page":"705","volume":"2","year":"1979","unstructured":"Hutchinson TA, Polansky SM, Feinstein AR. Post-menopausal oestrogens protect against fractures of hip and distal radius: a case-control study. Lancet. 1979; 2: 705\u2013709.","journal-title":"Lancet"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198011203032102"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198510243131703"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410120009002"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03330310033022"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92138-3"},{"key":"e_1_3_2_123_2","first-page":"277","volume":"53","year":"1979","unstructured":"Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol. 1979; 53: 277\u2013281.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_124_2","first-page":"1021","volume":"82","year":"1993","unstructured":"Hemminki E, Sihvo S. A review of postmenopausal hormone therapy recommendations: potential for selection bias. Obstet Gynecol. 1993; 82: 1021\u20131028.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90068-C"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6939.1268"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614156"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197401032900104"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-197907000-00017"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90077-O"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03300110022020"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(91)90193-T"},{"key":"e_1_3_2_133_2","first-page":"1027.","volume":"348","year":"1996","unstructured":"Daly E, Vessey MP, Painter R, Hawkins MM. Case-control study of venous thromboembolism risk in users of hormone replacement therapy. Lancet. 1996; 348: 1027.","journal-title":"Lancet"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009461"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7083.796"},{"key":"e_1_3_2_136_2","first-page":"477","volume":"278","year":"1997","unstructured":"Grady D, Furberg C. Venous thromboembolic events associated with hormone replacement therapy. JAMA. 1997; 278: 477","journal-title":"JAMA"},{"key":"e_1_3_2_137_2","first-page":"689","volume":"132","year":"2000","unstructured":"Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghoke D, Vittinghoff E, Hulley S. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med. 2000; 132: 689\u2013696.","journal-title":"Ann Intern Med"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614363"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605"},{"key":"e_1_3_2_140_2","first-page":"1338.","volume":"355","year":"2000","unstructured":"Larkin M. Ups and downs for HRT and heart disease. Lancet. 2000; 355: 1338.","journal-title":"Lancet"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613857"},{"key":"e_1_3_2_142_2","unstructured":"Rosendaal FR Vessey M Rumley A Daly E Woodward M Helmerhorst FM Lowe GDO. Hormonal replacement therapy prothrombotic mutations and the risk of venous thrombosis. Br J Haematol In press."},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.7.906"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649849"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650651"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1991.tb15364.x"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90888-1"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.20.5.1404"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615889"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615216"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)85011-3"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.23.2189"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00733.x"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650313"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7065.1127"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.104.4.499"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(75)90517-7"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112646"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112803"},{"key":"e_1_3_2_161_2","first-page":"91","volume":"69","year":"1987","unstructured":"Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol. 1987; 69: 91\u201395.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_162_2","first-page":"417","volume":"67","year":"1989","unstructured":"Cardiovascular disease and use of oral contraceptives: WHO Collaborative Study. Bull World Health Organ. 1989; 67: 417\u2013423.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1974.tb70899.x"},{"key":"e_1_3_2_164_2","first-page":"22","volume":"71","year":"1978","unstructured":"Diddle AW, Gardner WMH, Williamson PH, Johnson JR, Hemphill JL, Godwin CW. Oral contraceptives steroids and thrombophlebitis. J Tenn Med Assoc. 1978; 71: 22\u201326.","journal-title":"J Tenn Med Assoc"},{"key":"e_1_3_2_165_2","first-page":"1","volume":"66","year":"1985","unstructured":"Porter JB, Hunter JR, Jick H, Stergachis A. Oral contraceptives and nonfatal vascular disease. Obstet Gynecol. 1985; 66: 1\u20134.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_166_2","first-page":"259","volume":"38","year":"1971","unstructured":"Fuertes de la Haba A, Curet JO, Pelegrina I, Bangdiwala I. Thrombophlebitis among oral and nonoral contraceptive users. Obstet Gynecol. 1971; 38: 259\u2013263.","journal-title":"Obstet Gynecol"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/hq0202.102318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:30:20Z","timestamp":1715653820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/hq0202.102318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":166,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1161\/hq0202.102318"],"URL":"https:\/\/doi.org\/10.1161\/hq0202.102318","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"2002-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}